Join us for our first online Mindfulness + Community Chat session with Nurse Practitioner and bestselling author of “Today Mantras with Megan”, Megan Weigel! Megan will discuss the importance of mindfulness and its positive effect on patients. Participants will then be guided through a 15-minute mindfulness exercise. Anyone is welcome, no matter where you are located. If you are an individual diagnosed or a care partner for someone with ADEM, AFM, MOGAD, NMOSD, ON, or TM, we invite you to join us.
Disclaimer: Megan is not a mental health professional and cannot provide individualized medical or psychological advice.
SRNA 2023 education and support programs are supported by donations from our community and in part through grants from
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. They apply scientific expertise and courage to bring clinically meaningful therapies to patients. Horizon believes science and compassion must work together to transform lives.
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit https://www.gene.com.
* All educational content and programs are solely developed by the SRNA staff, members of the scientific board and approved by Board of Directors.
